2018, Number 4
Medicentro 2018; 22 (4)
Sánchez AML, Peral SML, Guirado CR, Alegret RM, Delgado CN
PDF size: 188.40 Kb.
ABSTRACTIntroduction: HIV/AIDS has become in a chronic disease. Antiretroviral therapy increases life expectancy but also evidences metabolic alterations, mainly those related to lipid profile. Atherosclerosis may be more frequent or can be developed quickly in individuals with HIV, especially in subjects treated with potent combination antiretroviral therapy. It is therefore necessary to treat cardiovascular risk as part of the follow-up of the HIV patient.
Objective: to estimate cardiovascular risk in a group of individuals with HIV using OMS/ISH AMR A risk- prediction charts.
Methods: a cross-sectional descriptive study was carried out in individuals with HIV belonging to Villa Clara province from January to December, 2016. Sample was constituted by 103 patients.
Results: the studied sample had a low risk of having a cardiovascular event in the next 10 years. Male gender with a mean age of 40 years predominated. Smoking habits and hypercholesterolemia were among the cardiovascular risk factors.
Conclusions: the approach of cardiovascular risk should be considered as part of the integral follow-up of HIV patients.